查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1821621

2025年全球細胞增殖市場報告

Cell Expansion Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年細胞增殖市場規模將快速成長，到2029年將達到593.1億美元，複合年成長率為16.4%。預測期內的成長歸因於生物技術投資的增加、幹細胞研究、臨床試驗和藥物開發的擴展、個人化醫療的需求以及生物生物銀行和細胞庫的建立。預測期內的主要趨勢包括技術進步、產品創新和策略聯盟。

未來五年16.4%的成長率預測比我們先前的預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。貿易摩擦可能導致新加坡和日本開發的自動化細胞培養系統和GMP級開發培養基價格上漲，阻礙美國再生醫學的發展，造成生產瓶頸，導致臨床試驗延遲三至六個月。由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易的負面影響，貿易摩擦的影響可能更為廣泛。

慢性病盛行率的上升預計將在未來推動細胞增殖市場的需求。慢性病是一種長期疾病，有時可以控制或管理，但通常無法治癒。其盛行率的上升是由於吸煙、營養不良、缺乏運動和過量飲酒等因素造成的。細胞增殖在補充營養和防止可能影響文化表現的有毒代謝廢物累積方面發揮關鍵作用。例如，美國國家醫學圖書館下屬的國家生物技術資訊中心 (NCBI) 在 2023 年 1 月預測，到 2050 年，患有至少一種慢性病的 50 歲及以上人群的數量將增加 99.5%，從 2020 年的 7,152.2 萬人增加到 1.4266 億人。因此，慢性病盛行率的上升預計將推動細胞增殖市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球細胞生長：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球細胞增生市場：成長率分析
  • 全球細胞增殖市場表現：規模與成長，2019-2024
  • 全球細胞增殖市場預測：規模與成長，2024-2029年，2034年
  • 全球細胞增生：總目標市場（TAM）

第6章 市場細分

  • 全球細胞擴增市場：按細胞類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 哺乳動物
  • 微生物
  • 其他細胞類型
  • 全球細胞增殖市場：依產品、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 耗材
  • 試劑
  • 培養基
  • 血清
  • 一次性的
  • 裝置
  • 全球細胞增殖市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 生物製藥
  • 組織培養與工程
  • 疫苗生產
  • 藥物開發
  • 基因治療
  • 癌症研究
  • 幹細胞研究
  • 其他用途
  • 全球細胞擴增市場：按最終用戶、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 生物製藥和生物技術公司
  • 研究所
  • 細胞庫
  • 其他最終用戶
  • 全球細胞增殖市場：按哺乳動物、類型、表現和預測的細分，2019-2024 年、2024-2029 年、2034 年
  • 貼壁細胞
  • 懸浮細胞
  • 幹細胞
  • 全球細胞擴增市場：按微生物、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 細菌細胞
  • 酵母菌細胞
  • 真菌細胞
  • 全球細胞增殖市場：其他細胞類型細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 植物細胞
  • 昆蟲細胞
  • 融合瘤

第7章 區域和國家分析

  • 全球細胞增殖市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球細胞增殖市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 細胞增殖市場：競爭格局
  • 細胞增殖市場：公司簡介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group Overview, Products and Services, Strategy and Financial Analysis
    • Corning Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Sartorius Stedim Biotech SA
  • Terumo Corporation
  • Miltenyi Biotec GmbH
  • Danaher Corporation
  • Stemcell Technologies Inc.
  • Beckman Coulter Inc.
  • Takara Bio Inc.
  • RepliCel Life Sciences
  • Neximmune Inc.
  • Celltainer Biotech BV
  • GE HealthCare Technologies Inc.
  • ReproCELL USA Inc.
  • iXCells Biotechnologies Inc.
  • Neuromics LLC
  • G&G Technologies Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年細胞增生市場：提供新機會的國家
  • 2029 年細胞增殖市場：細分領域帶來新機會
  • 2029年細胞增殖市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r22455u

Cell expansion is a cellular process employed to generate new cell wall material, with the primary objective of regulating the flexibility of the wall and facilitating its stretching and expansion in a specific area. Essential to this process are cell-wall-associated proteins belonging to the expansion family.

The main categories of cell expansion include mammalian, microbial, and other types. Mammalian cell expansion involves the cultivation of cells derived from mammals, conducted through the in vitro cultivation of cells in flasks or bioreactors. The products associated with mammalian cell expansion encompass consumables, reagents, media, serums, disposables, and instruments. These products find application in various fields such as biopharmaceuticals, tissue culture and engineering, vaccine production, drug development, gene therapy, cancer research, stem cell research, and others. The end-users of mammalian cell expansion products include biopharmaceutical and biotechnology companies, research institutes, cell banks, and other relevant entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cell expansion market research report is one of a series of new reports from The Business Research Company that provides cell expansion market statistics, including cell expansion industry global market size, regional shares, competitors with a cell expansion market share, detailed cell expansion market segments, market trends and opportunities, and any further data you may need to thrive in the cell expansion industry. This cell expansion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell expansion market size has grown rapidly in recent years. It will grow from $28.11 billion in 2024 to $32.31 billion in 2025 at a compound annual growth rate (CAGR) of 15.0%. The growth in the historic period can be attributed to public awareness and acceptance, cell-based research applications, rising demand for cell-based therapies, biopharmaceutical industry growth, regenerative medicine advancements.

The cell expansion market size is expected to see rapid growth in the next few years. It will grow to $59.31 billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to rising investments in biotechnology, expanding stem cell research, clinical trials and drug development, demand for personalized medicine, biobanking and cell repositories. Major trends in the forecast period include technological advancements, product innovations, strategic collaborations.

The forecast of 16.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. regenerative medicine by inflating prices of automated cell culture systems and GMP-grade expansion media developed in Singapore and Japan, resulting in production bottlenecks that delay clinical trials by 3-6 months. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of chronic diseases is anticipated to drive the demand for the cell expansion market in the future. Chronic diseases are long-lasting conditions that often cannot be cured, although they can sometimes be managed or controlled. Their increasing prevalence is attributed to factors such as tobacco use, poor nutrition, physical inactivity, and excessive alcohol consumption. Cell expansion plays a crucial role in replenishing nutrients and preventing the buildup of toxic metabolic waste products that could hinder culture performance. For instance, in January 2023, the National Center for Biotechnology Information (NCBI), part of the US National Library of Medicine, projected that by 2050, the number of individuals aged 50 and older with at least one chronic illness will rise by 99.5%, increasing from 71.522 million in 2020 to 142.66 million. Consequently, the growing incidence of chronic diseases is expected to boost the growth of the cell expansion market.

The growth of the cell expansion market is expected to be propelled by increasing government funding for research and development. Government funding plays a crucial role in fostering innovation, advancing cell-based therapies, and accelerating progress in regenerative medicine. An illustrative example is the National Cancer Institute, a US-based government agency, which received a budget of $7.3 billion in fiscal year 2023 from the United States Congress, marking a $408 million increase from 2022. This substantial increase in government funding for research and development is a driving force behind the growth of the cell expansion market.

Leading companies in the cell expansion market are focusing on advancements in bioprocessing technologies, such as automated 3D bioreactor systems, to improve the efficiency and scalability of cell production for therapeutic purposes. PluriCDMO specializes in large-scale, automated manufacturing of cell therapies utilizing a proprietary 3D bioreactor system, ensuring consistent, high-quality production from early development to clinical trials. For example, in January 2024, Pluristem Therapeutics Inc., a biotechnology company based in Israel, launched a new division called PluriCDMO that will provide cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). This new division features a 47,000-square-foot good manufacturing practice (GMP) facility dedicated to cell therapy production. Through PluriCDMO, the company will offer services ranging from early preclinical development to late-stage clinical trials and commercialization.

Major companies in the cell expansion market are intensifying their focus on introducing advanced bioprocessing platforms, such as the Quantum Flex Cell Expansion System, to gain a competitive edge. The Quantum Flex Cell Expansion System, launched by Terumo Blood and Cell Technologies in June 2023, is designed for scalable and flexible expansion of cell therapies, providing efficient and controlled manufacturing capabilities for cell-based medical treatments. This system supports the expansion of various applications, including suspension and adherent cells, viral vectors, and exosome production, offering the necessary flexibility, scalability, and connectivity to support the growth of cell therapies.

In a strategic move, Sartorius AG, a Germany-based pharmaceutical company, acquired Polyplus-Transfection SA for $2.36 billion in March 2023. This acquisition positions Sartorius AG to strengthen its supply of cell and gene therapy solutions, expanding its portfolio for gene therapies and gene-modified cell therapies. Polyplus-Transfection SA, based in France, is a biotechnology company supporting gene and cell therapy, biologics manufacturing, and life science research.

Major companies operating in the cell expansion market are Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group, Corning Inc., Merck KGaA, Sartorius Stedim Biotech SA, Terumo Corporation, Miltenyi Biotec GmbH, Danaher Corporation, Stemcell Technologies Inc., Beckman Coulter Inc., Takara Bio Inc., RepliCel Life Sciences, Neximmune Inc., Celltainer Biotech BV, GE HealthCare Technologies Inc., ReproCELL USA Inc., iXCells Biotechnologies Inc., Neuromics LLC, G&G Technologies Inc., Eppendorf AG, Avantor Inc., Bio-Techne Corporation, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd., Lifeline Scientific Inc., Princeton Cryotech Inc., VWR International LLC, Azenta US Inc., MVE Biological Solutions LLC, BioCision LLC, BioSpherix Ltd., Worthington Industries Inc.

North America was the largest region in the cell expansion market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell expansion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell expansion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell expansion market includes revenues earned by entities by providing bioreactors and automated cell expansion systems. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Expansion Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell expansion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell expansion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell expansion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Cell Type: Mammalian; Microbial; Other Cell Types
  • 2) By Product: Consumables; Reagents; Media; Serum; Disposables; Instruments
  • 3) By Application: Biopharmaceuticals; Tissue Culture And Engineering; Vaccine Production; Drug Development; Gene Therapy; Cancer Research; Stem Cell Research; Other Applications
  • 4) By End-user: Biopharmaceutical And Biotechnology Companies; Research Institutes; Cell Banks; Other End-Users
  • Subsegments:
  • 1) By Mammalian: Adherent Cells; Suspension Cells; Stem Cells
  • 2) By Microbial: Bacterial Cells; Yeast Cells; Fungal Cells
  • 3) By Other Cell Types: Plant Cells; Insect Cells; Hybridoma Cells
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Becton Dickinson and Company; Lonza Group; Corning Inc.; Merck KGaA; Sartorius Stedim Biotech SA; Terumo Corporation; Miltenyi Biotec GmbH; Danaher Corporation; Stemcell Technologies Inc.; Beckman Coulter Inc.; Takara Bio Inc.; RepliCel Life Sciences; Neximmune Inc.; Celltainer Biotech BV; GE HealthCare Technologies Inc.; ReproCELL USA Inc.; iXCells Biotechnologies Inc.; Neuromics LLC; G&G Technologies Inc.; Eppendorf AG; Avantor Inc.; Bio-Techne Corporation; BioLife Solutions Inc.; Cesca Therapeutics Inc.; Core Dynamics Ltd.; Lifeline Scientific Inc.; Princeton Cryotech Inc.; VWR International LLC; Azenta US Inc.; MVE Biological Solutions LLC; BioCision LLC; BioSpherix Ltd.; Worthington Industries Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Expansion Market Characteristics

3. Cell Expansion Market Trends And Strategies

4. Cell Expansion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell Expansion Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cell Expansion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cell Expansion Market Growth Rate Analysis
  • 5.4. Global Cell Expansion Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cell Expansion Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cell Expansion Total Addressable Market (TAM)

6. Cell Expansion Market Segmentation

  • 6.1. Global Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mammalian
  • Microbial
  • Other Cell Types
  • 6.2. Global Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Reagents
  • Media
  • Serum
  • Disposables
  • Instruments
  • 6.3. Global Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceuticals
  • Tissue Culture And Engineering
  • Vaccine Production
  • Drug Development
  • Gene Therapy
  • Cancer Research
  • Stem Cell Research
  • Other Applications
  • 6.4. Global Cell Expansion Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical And Biotechnology Companies
  • Research Institutes
  • Cell Banks
  • Other End-Users
  • 6.5. Global Cell Expansion Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adherent Cells
  • Suspension Cells
  • Stem Cells
  • 6.6. Global Cell Expansion Market, Sub-Segmentation Of Microbial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacterial Cells
  • Yeast Cells
  • Fungal Cells
  • 6.7. Global Cell Expansion Market, Sub-Segmentation Of Other Cell Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plant Cells
  • Insect Cells
  • Hybridoma Cells

7. Cell Expansion Market Regional And Country Analysis

  • 7.1. Global Cell Expansion Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cell Expansion Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell Expansion Market

  • 8.1. Asia-Pacific Cell Expansion Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell Expansion Market

  • 9.1. China Cell Expansion Market Overview
  • 9.2. China Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell Expansion Market

  • 10.1. India Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell Expansion Market

  • 11.1. Japan Cell Expansion Market Overview
  • 11.2. Japan Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell Expansion Market

  • 12.1. Australia Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell Expansion Market

  • 13.1. Indonesia Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell Expansion Market

  • 14.1. South Korea Cell Expansion Market Overview
  • 14.2. South Korea Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell Expansion Market

  • 15.1. Western Europe Cell Expansion Market Overview
  • 15.2. Western Europe Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell Expansion Market

  • 16.1. UK Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell Expansion Market

  • 17.1. Germany Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell Expansion Market

  • 18.1. France Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell Expansion Market

  • 19.1. Italy Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell Expansion Market

  • 20.1. Spain Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell Expansion Market

  • 21.1. Eastern Europe Cell Expansion Market Overview
  • 21.2. Eastern Europe Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell Expansion Market

  • 22.1. Russia Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell Expansion Market

  • 23.1. North America Cell Expansion Market Overview
  • 23.2. North America Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell Expansion Market

  • 24.1. USA Cell Expansion Market Overview
  • 24.2. USA Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell Expansion Market

  • 25.1. Canada Cell Expansion Market Overview
  • 25.2. Canada Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell Expansion Market

  • 26.1. South America Cell Expansion Market Overview
  • 26.2. South America Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell Expansion Market

  • 27.1. Brazil Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell Expansion Market

  • 28.1. Middle East Cell Expansion Market Overview
  • 28.2. Middle East Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell Expansion Market

  • 29.1. Africa Cell Expansion Market Overview
  • 29.2. Africa Cell Expansion Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cell Expansion Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cell Expansion Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell Expansion Market Competitive Landscape And Company Profiles

  • 30.1. Cell Expansion Market Competitive Landscape
  • 30.2. Cell Expansion Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lonza Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Corning Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Cell Expansion Market Other Major And Innovative Companies

  • 31.1. Sartorius Stedim Biotech SA
  • 31.2. Terumo Corporation
  • 31.3. Miltenyi Biotec GmbH
  • 31.4. Danaher Corporation
  • 31.5. Stemcell Technologies Inc.
  • 31.6. Beckman Coulter Inc.
  • 31.7. Takara Bio Inc.
  • 31.8. RepliCel Life Sciences
  • 31.9. Neximmune Inc.
  • 31.10. Celltainer Biotech BV
  • 31.11. GE HealthCare Technologies Inc.
  • 31.12. ReproCELL USA Inc.
  • 31.13. iXCells Biotechnologies Inc.
  • 31.14. Neuromics LLC
  • 31.15. G&G Technologies Inc.

32. Global Cell Expansion Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Expansion Market

34. Recent Developments In The Cell Expansion Market

35. Cell Expansion Market High Potential Countries, Segments and Strategies

  • 35.1 Cell Expansion Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cell Expansion Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cell Expansion Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer